12 results on '"Dave, Hema"'
Search Results
2. Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
3. Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
4. Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
5. T-cell therapies for T-cell lymphoma
6. Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331
7. 227 - Intravenous Anakinra for Treatment of Icans/HLH-like Complications of Tisagenlecleucel
8. Tumor Associated Antigen Specific T Cells Given in Combination with Nivolumab for the Treatment of Hodgkin Lymphoma
9. Increased Tumor Specific Cytotoxic T Cell Responses and Reversion to a Favorable Cytokine Profile after Treatment in Patients with Newly Diagnosed High Risk Hodgkin Lymphoma Treated on Children's Oncology Group Trial-AHOD1331
10. 222 - Voriconazole Levels Indicate That Pediatric Prophylaxis Dosing May be Insufficient
11. 179 - Rapid Production of Multi-Virus Specific T Cells Targeting BKV, Adenovirus, CMV and EBV for Recipients of Umbilical Cord Blood Transplant
12. Chapter 6 - Analgesia and Sedation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.